Value Microcaps Zip Code Changers

[ProfitScout]

$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

MIAMI, Sept. 3, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, ("NRx," the "Company") and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary of NRx, today announced they will be featured as a presenting companies at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held on September 9-11, 2024.

The in-person venue for the event is the Lotte New York Palace Hotel in New York City located at 455 Madison Avenue. Virtual participation will be staged simultaneously with over 550 company presentations scheduled as live feed or available on-demand.

Jonathan Javitt, MD, MPH, Chairman and Chief Scientist of NRx and Co-CEO of Hope, will provide an overview of the Company's business during the presentation.

If you are an institutional investor, and would like to listen to the Company's presentation, please click on the following link (www.hcwevents.com/annualconference) to register for the conference.

Event: H.C. Wainwright 26th Annual Global Investment Conference

Date: September 9-11, 2024

Location: Virtual to start on-demand on September 9 at 7:00 A.M. (ET) or in-person at the Lotte New York Palace Hotel, New York, NY.

Access to the presentation can also be found at https://ir.nrxpharma.com/events beginning at 7:00AM ET Monday September 9, 2024.

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

About HOPE Therapeutics, Inc.

HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a healthcare delivery company developing a best-in-class network of clinics that currently offer ketamine and other lifesaving therapies to patients with suicidal depression and related disorders, together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.

About H.C. Wainwright & Co.

H.C. Wainwright is a full–service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. H.C. Wainwright & Co. also provides research and sales and trading services to institutional investors. According to Sagient Research Systems, H.C. Wainwright's team is ranked as the #1 Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) executed cumulatively since 1998.

For more information visit H.C. Wainwright & Co. on the web at www.hcwco.com

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.

For further information:

CORPORATE CONTACTS:
Jeremy Feffer, LifeSci Advisors, Inc.
[e-mail]

Matthew Duffy
Chief Business Officer, NRx Pharmaceuticals
Co-CEO, HOPE Therapeutics, Inc.
[e-mail]


https://c212.net/c/img/favicon.png?sn=CL96063&sd=2024-09-03 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-and-hope-therapeutics-inc-announce-participation-at-the-hc-wainwright-26th-annual-global-investment-conference-september-9-11-2024-302236168.html

SOURCE NRx Pharmaceuticals, Inc.

[ProfitScout]

$GDHG News: Golden Heaven Group Holdings Ltd. Secures Plot in Yangzhou's Yunhe Sanwan Scenic Spot for New Amusement Complex and Extends Strategic Partnership with Dacheng Culture

NANPING, China, Aug. 27, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced that it was granted the land use rights for an approximately 26,000-square-meter plot (the "Plot") located in Yunhe Sanwan Scenic Spot in Yangzhou, Jiangsu Province, China on August 16, 2024 by Yangzhou Lemandi Tourism Development and Investment Co., Ltd. The Company plans to launch a new recreation and amusement complex at this site, with commercial operations anticipated to begin in October 2024.

Situated within the Yunhe Sanwan Scenic Spot, which is geographically close to the Beijing-Hangzhou Grand Canal, the world's longest man-made waterway, the Plot offers substantial advantages. By securing the land use rights in such a popular tourist attraction of significant historical and cultural importance, as well as a location with high foot traffic, the Company anticipates growth opportunities to be derived from introducing innovative amusement rides to enhance the park's appeal and competitiveness in the market.

This development marks the second collaboration between the Company and Nanping City Dacheng Culture Communication Co., Ltd., ("Dacheng Culture") in co-developing attraction projects. The two parties have signed a one-year collaboration agreement (the "Agreement") valued at RMB1.2 million on August 19, 2024. Under the Agreement, Golden Heaven agrees to lease certain land and property to Dacheng Culture for activities such as wedding photography, traditional costume photography, and various celebratory events. In return, Dacheng Culture agrees to pay to the Company an aggregate lease payment of RMB1.2 million, over the term of the Agreement, which extends from August 19, 2024 to August 18, 2025.

Mr. Jin Xu, CEO and Chairman of the Company, commented, "We are thrilled to have obtained the land use rights for this plot within the Yunhe Sanwan Scenic Spot. Located in a bustling area of Yangzhou with beautiful surroundings and high foot traffic, it is an ideal destination for tourists, families and young couples. Our goal is to create an amusement park that seamlessly integrates entertainment and leisure experiences with a variety of cultural activities."

Mr. Xu added, "The continued partnership with Dacheng Culture is a testament to the win-win alliance between two industry leaders. By synergizing the unique advantages, resources and innovative capabilities of both sides, we will not only enhance the cultural depth and entertainment value of our park but also expand our market influence. We look forward to working with Dacheng Culture to write a new chapter for the cultural tourism and leisure entertainment industry of the city."

About Golden Heaven Group Holdings Ltd.

The Company is an offshore holding company incorporated in the Cayman Islands with no material operations of its own. Through its Chinese operating entities, the Company manages and operates amusement parks, water parks and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. For more information, please visit the Company's website at https://ir.jsyoule.com/.

Forward-Looking Statements

This press release contains "forward-looking statements". Forward-looking statements reflect our current view about future events. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "could," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "propose," "potential," "continue" or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

Golden Heaven Group Holdings Ltd.
Email: [e-mail]

Ascent Investor Relations LLC
Phone: [phone]
Email: [e-mail]

https://c212.net/c/img/favicon.png?sn=CN91507&sd=2024-08-27 View original content:https://www.prnewswire.com/news-releases/golden-heaven-group-holdings-ltd-secures-plot-in-yangzhous-yunhe-sanwan-scenic-spot-for-new-amusement-complex-and-extends-strategic-partnership-with-dacheng-culture-302230780.html

SOURCE Golden Heaven Group Holdings Ltd.

[ProfitScout]

$IDVV News: Winners Waygers AI Powered Sports Handicapping Assistant Launched In Beta

Carlsbad, California--(Newsfile Corp. - August 15, 2024) - International Endeavors Corp. (OTC Pink: IDVV) ("IEC"), a technology holdings company announced that its WITech.ai division launched a one of a kind artificial intelligence (AI) powered sports handicapping assistant today.

We are pleased to announce the launch of winnerswaygers.com in a free beta mode today thus expanding our AI's ability into sports handicapping. IEC's WITech division plans to expand the service quickly into a subscription based model featuring all major sports using the popularity of the NFL football and fantasy betting season as a catalyst to make users aware of the service.

The AI is currently used by professional handicappers that helped to develop the tools and datasets for the AI. WITech is transforming the current complex model into a user friendly service that will appeal to all.

Current plans are to launch in phases starting with a beta mode offering users the ability to sign up for the service for free. Upon the start of the NFL season in September 2024 users will begin receiving handicapping information from the AI to assist in their decision making.

Our goal after beta is to launch our paid subscription service featuring an interactive sports handicapping bot in Mid October 2024 along with an expansion into Hockey and Basketball. We will be offering a discount to any users of the beta version who wish to upgrade at that time.

We are planning in Q4 of 2024 to begin charging $77 per league selected, for example NFL, and will offer an all sports league package for $247 per year/season. As previously indicated there will be a discount for beta members. At that time the beta version will become a free weekly newsletter featuring one pick to allow potential paid subscribers to see how the service works. We have been seeing massive interest in this service and feel we will have thousands of subscribers as the paid service gets rolled out.

Winners Waygers spokesperson Marrion Lewis stated, "We are excited offer the service to the mainstream. For far too long only professionals have had access to the complex data used to make more accurate sports bets. We plan to change the game. The NFL is the most popular sport to bet, so it is fitting to use it for our launch. I'm personally rooting for the chiefs, but we'll let the AI decide."

IDVV board member Ray Valdez stated, "This is the first expansion of the company into adult related, and more importantly recession resilient sectors. With the potential of many thousands of subscribers we are looking forward to discussing winners waygers along with other opportunities the company is pursuing shortly."

Winners Waygers Video
https://vimeo.com/999064151?share=copy

Relevant Links
https://www.americangaming.org/resources/economic-impact-of-legalized-sports-betting/
https://www.statista.com/topics/10895/fantasy-sports-in-the-us/#topicOverview
https://www.espn.com/nfl/story/_/id/39469575/americans-expected-bet-231b-super-bowl-lviii

We encourage everyone to follow us.

Twitter
https://twitter.com/IDVVcorp

Website(s)
https://witech.ai
https://IDVVCORP.COM

About Us
International Endeavors Corporation ("IEC") is a technology holdings company.
The Company currently is reporting its financial information on OTCMarkets.
Our filings can be seen at https://www.otcmarkets.com.

Disclaimer
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

International Endeavors Corporation
Phone:[phone]
Email: [e-mail]

SOURCE: International Endeavors Corporation, Inc.

https://images.newsfilecorp.com/files/10187/220044_9ae4a1780431c9ef_logo.jpg

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/220044

SOURCE International Endeavors Corporation

https://api.newsfilecorp.com/newsinfo/220044/130

[ProfitScout]

$GDHG: Golden Heaven Group Holdings Ltd. Announces Financial Results for the First Half of Fiscal Year 2024
News Link:
https://www.prnewswire.com/news-releases/golden-heaven-group-holdings-ltd-announces-financial-results-for-the-first-half-of-fiscal-year-2024-302210279.html#:~:text=The%20total%20revenue%20decreased%20by,in%20the%20First%20Half%202024.

[ProfitScout]

$AVRW Avenir Wellness Solutions™ ($AVRW) Skin Care Products are Sold at Walmart $WMT , Target $TGT , CVS Health $CVS , and Amazon $AMZN Retail Outlets. Accelerating Sales for Superior Anti-Aging Skin Care Line with Direct Endorsement of Nicole Kidman
Click here:
https://www.einpresswire.com/article/660866879/accelerating-sales-for-superior-anti-aging-skin-care-line-with-direct-endorsement-of-nicole-kidman-stock-symbol-avrw

[SSKILLZ1]

Savvy Pick 10 Contest #1 Deadline a Little more than 4 Hour Away

Remember to get your picks in before Today's Market Close. Below is the link to the board.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

[SSKILLZ1]

Savvy Pick 10 Contest #1 Deadline Before Friday Market Close (6/28)

Remember to get your picks in before Friday's Market Close (6/28). Below is the link to the board.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057

Note: Remember when you make your picks let me know what is your top pick.

Contest Announcement Post

This link announces the contest and give brief detail of some of the rules of the contest. for more info. on the rules the I-box of the Savvy Pick 10 Contest #1 Board for more details. Hope this helps.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174610885

[ProfitScout]

$SHOT: Wellness And Dietary Supplement Company Safety Shot Reports Bringing World's First Patented Rapid Blood Alcohol Detox Solution To Market - Safety Shot (NASDAQ:SHOT) - Benzinga
Click here:
https://www.benzinga.com/partner/emerging-markets/24/06/39361121/wellness-and-dietary-supplement-company-safety-shot-reports-bringing-worlds-first-patent

[Zardiw]

New Bio Tech Company: $CATV

Merging with Genetic Networks LLC



Z

[ProfitScout]

$CATV: Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector

MIAMI, May 15, 2024 /PRNewswire/ -- 4Cable TV International, Inc. soon to be known as Category V Biotech, Inc. (OTC: CATV) announced today the execution of a Letter of Intent (LOI) to acquire Genetic Networks, LLC (https://geneticnetworks.com/), a leader in applied molecular biology and drug development. Effective May 15, 2024, the LOI signifies Category V Biotech's acquisition of 100% equity interests in Genetic Networks, marking the company's entry into the biotechnology sector of the Cannabis industry and solidifying its position as a fully integrated global leader in this space.

Genetic Networks brings a proprietary platform known as GeneScape™, which facilitates the rapid and unbiased discovery of optimal drug compounds through whole-genome analysis. By integrating functional assays of drug activity and human gene variants, GeneScape™ can identify the most promising targets and compounds for specific diseases, expediting development timelines and reducing costs. This acquisition enables Category V Biotech to expand into the biotech aspect of the Cannabis industry, leveraging Genetic Networks' expertise in accelerating compound discovery and development for pre-clinical and clinical testing.

"We are excited to welcome Genetic Networks into the Category V Biotech family," stated Michael Feldenkrais, CEO of Category V Biotech. "Their state-of-the-art platform and extensive knowledge will be instrumental as we strive to unlock the full potential of Cannabis-based therapeutics. Together, we anticipate bringing novel treatments to patients faster than ever before as regulated FDA products under the new regulatory environment of the United States."

Under the agreement's terms, Category V Biotech will acquire 100% of Genetic Networks. The transaction is expected to conclude in the second quarter of 2024, pending customary closing conditions.

Dr. Gennaro D'Urso, co-founder of Genetic Networks, echoed this enthusiasm, stating, "Category V Biotech shares our dedication to leveraging genetics to revolutionize drug development. By joining forces, we envisage broadening the reach and impact of our platform, ultimately delivering superior medicines to patients in need."

Following the acquisition, Genetic Networks will operate as a wholly owned subsidiary of Category V Biotech, retaining its existing management team and facilities. Category V Biotech plans to leverage Genetic Networks' capabilities across its global Cannabis operations, including cultivation, biotech research, and retail.

This transaction is the culmination of years of discussions, awaiting the right moment for research and development in the United States to create pharmaceutical-grade products using Cannabis. With the recent announcement of the rescheduling of Cannabis from Controlled Substance I to Controlled Substance III, reflecting a change in U.S. policies, the long-awaited strategy can now come to fruition. This shift paves the way for Category V Biotech and Genetic Networks to capitalize on emerging opportunities in the Cannabis industry, driving innovation and advancing therapeutic solutions for patients.

Category V Biotech remains actively engaged in pursuing additional acquisitions in the Cannabis industry as part of its growth strategy, with further transactions expected to be announced in the coming months.

About Genetic Networks, LLC

Genetic Networks, LLC, established in 2015, has been at the forefront of serving three of the top ten bio-pharmaceutical companies with its GeneScape™ technology. GeneScape™ expedites drug asset development through applied molecular biology, offering a multidimensional map of diseases and drugs that integrates genome-wide functional assays of drug activity (H-Tech) and human genes and gene variants (Y-Tech) using proprietary analytics. Genetic Networks' GeneScape™ platform accelerates the discovery and development of optimal candidate compounds for pre-clinical and clinical testing, identifying the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.

About Category V Biotech, LLC, Inc.

Category V Biotech, LLC, Inc. (OTC: CATV) aims to establish and operate a fully integrated global Cannabis company, encompassing biotech research, cultivation, manufacturing, and retail. Through strategic acquisitions and organic growth, the company strives to emerge as the world's leading provider of pharmaceutical Cannabis- based products and therapies.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements regarding Category V Biotech, LLC's business, which are not historical facts but are based on the company's current beliefs, expectations, and assumptions about its future business, plans, strategies, projections, anticipated events, and trends. Such forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are beyond the company's control. Actual results and financial conditions may differ materially from those indicated in the forward- looking statements due to various factors. The company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, made from time to time, except as required by law.

SOURCE: 4Cable TV International, Inc a/k/a Category V Biotech, LLC, Inc. (OTC: CATV)

Contact: [e-mail], [phone]

Cision View original content:https://www.prnewswire.com/news-releases/category-v-biotech-inc-announces-letter-of-intent-to-acquire-genetic-networks-expanding-into-biotechnology-sector-302146392.html

SOURCE 4Cable TV International, Inc.

[SSKILLZ1]

Pick 4 Contest #20 Deadline Slightly more than 4 Hours Away (5/17/24)

Remember to get your picks in before Today's Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-20-42933

[SSKILLZ1]

Pick 4 Contest #20 Deadline Friday (5/17/24)

Remember to get your picks in before Friday's Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-20-42933

[ProfitScout]

$IVDN (16 million float) is on track for a record sales and revenue growth year in 2024, as detailed in official company news below. IVDN management is making steady progress to grow market share and also protect the very valuable patent rights of its unique Insultex product line which is the only evacuated cell insulation on the market with energy saving performance that no competitor can match.

IVDN is now starting to see accelerating sales success as word is spreading about Insultex House Wrap as described on the dedicated website at http://www.insultexhousewrap.com. Add to this advantage, the fact that the IVDN product meets or exceeds new building codes going into effect this year requiring continuous insulation while competitors are failing this critical criteria.

Innovative Designs Vendor Growth
April 10, 2024
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html

World International Patent Organization (WIPO) Application Accepted on Superior Insulation Advancement to Maximize Global Marketing Opportunities for Innovative Designs, Inc.
Dec. 27, 2023
https://www.newmediawire.com/news/world-international-patent-organization-wipo-application-accepted-on-superior-insulation-advancement-to-maximize-global-marketing-opportunities-for-innovative-designs-inc-7071640

LIG Assets, Inc. Announces Agreement With Insultex House Wrap
October 30, 2023
https://www.globenewswire.com/en/news-release/2023/10/30/2769422/0/en/LIG-Assets-Inc-Announces-Agreement-With-Insultex-House-Wrap.html

Innovative Designs Inc. Receiving Orders From Numerous New Client Accounts for Top Performing Insultex House Wrap With Unmatched R-6 Insulation Value
October 26, 2023
https://www.globenewswire.com/news-release/2023/10/26/2767843/0/en/Innovative-Designs-Inc-Receiving-Orders-From-Numerous-New-Client-Accounts-for-Top-Performing-Insultex-House-Wrap-With-Unmatched-R-6-Insulation-Value.html

Innovative Designs Adds New Accounts
October 2, 2023
https://www.globenewswire.com/news-release/2023/10/02/2752606/0/en/Innovative-Designs-Adds-New-Accounts.html

[SSKILLZ1]

Pick 4 Contest #19 Less Than 4 Hour Away

Remember to get your picks in before Today's Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-19-42580

[SSKILLZ1]

Pick 4 Contest #19 Deadline Tomorrow

Remember to get your picks in before Tomorrow's Close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-19-42580

[SSKILLZ1]

Pick 4 Contest #18 Deadline Today Is less than 3 Hours Away

Remember to get your picks in before Today’s market close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-18-42038

[SSKILLZ1]

Pick 4 Contest #18 Deadline Tomorrow

Remember to get your picks in before Friday’s market close. Below is the link to the board. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-18-42038

[SSKILLZ1]

Pick 4 Contest # 17 Deadline Just a little over 2 Hours Away

Remember to get your picks in before Today's Close. Below is the link to the board.

https://investorshub.advfn.com/Pick-4-Contest-No-17-41659

[NWriter]

#RGC Live on SSN Network - Results of TCM’s Effectiveness to Treating COVID19

Regencell Bioscience Limited is a Hong Kong company which is fronting the uses of Traditional Chinese Medicine (”TCM”) to treat not only ADHD and ASD but also Covid-19 which shook the world back in 2020.

Regencell Bioscience Holdings (RGC: Nasdaq) is a an early-staged bioscience healthcare company focusing on R&D and commercilisation of Traditional Chinese Medicine (TCM) for the treatment of neurocognitive disorders and degenerations.

In latest findings, RGC has treatment formula has test treated 19 patients (suspected or confirmed COVID cases). 12 of 19 patients which were treated exhibited improvements in their recovery after an average treatment period of 5 days.

An interview was held onf SSN Network (The Official Small-, Micro- and Nano-Cap News Source™) which included Jay Lee, CEO of Regencell Bioscience Asia Limited, and Paul Niewiadomski, Independent Director; where they talk about the company, the procedures and protocols of their treatments and result findings.

[https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html](https://finance.yahoo.com/news/regencell-describes-traditional-chinese-medicine-133000084.html)

Separately, while Mr Au, the company’s CEO and chairman was not included as part of the interview, he has been working in in the background in defending his company from the recent short seller and trader attacks on the company stock. Mr Au has bought back over $5 Million Dollars of company share since taking the company IPO.

Mr Au has mentioned “While the research is still ongoing, we strongly believe that our formula can make a difference in the fight against COVID-19."

Aside from the company’s positive progress in medical, the CEO (Mr Au) has shown his confidence in the progress of the company direction and not sold a single share since taking his company to Initial Public Offering (”IPO”) in Year 2020. Mr Au has pledged to not take salary and bonus (<1$) until the company reaches US$1 Billion market cap as his target.

https://www.biospectrumasia.com/news/48/18957/regencell-bio-to-offer-traditional-medicines-for-covid-19-treatment-in-asean-countries.html

[SteveSchiets]

The CEO spoke about it in an interview, less then 2 years ago. Said their name, Working with Sony on their new headmounted display.

During that time it could have fallen through but it didn’t.

[CPTMatt]

How did you come by this info in that case? Thanks

[SteveSchiets]

If you have the time, H1may be profitable, else it will be Q3/Q4

[SteveSchiets]

SEV.V

Or

spvnf

[jtomm]

Sounds interesting, but looks like they haven't been close to profitable thus far. Can you provide any further insight on why you think they'll be profitable this year?

[SSKILLZ1]

Pick 4 Contest # 16 Deadline In Less Than 4 Hours Away

Remember to get your picks in before Today’s Close. Below is the link to the board.

https://investorshub.advfn.com/Pick-4-Contest-No-16-41115

[nsomniyak]

What's the symbol on that, Steve?

[SSKILLZ1]

Pick 4 Contest # 16 Deadline Friday

Remember to get your picks in before Friday’s Close. Below is the link to the board.

https://investorshub.advfn.com/Pick-4-Contest-No-16-41115

[SteveSchiets]

I bought more Spectra7 shares yesterday. Hiding in plane sight. S7 will provide the cable for the new PSVR2. A contract for multiple years. Due to NDA reasons this news is not out there.

MC of 20$ million for this profitable company this year.

[SteveSchiets]

Thx Zen. Very interesting. I will watch the documentary first

[zenvesting]

Verde Agritech (NPK.to/AMHPF) has had an incredible run that was a major part of my win of the Pick 4 contest.

There is a board on I-Hub with not much traffic, but I want to share it here to, as I believe it still has zip code changing potential from here, albeit probably at a slower pace than over the past six months.

Verde has an unconventional source of Potash, located within one of the world's richest agricultural economies, where they import 99% of their potash needs. Verde's glauconite derived "Supergreen sand" is only 10% potasium (K), where as conventional KCl is 60% K, so it takes about 6x more of Verde's material than typical potash. The company charges per pound of K, so it charges the market rate for K in traditional KCl. This aspect has made it a hard sell, but the farmers trialing the product have raved about how it improved plant health in forage crops like bananas and coffee, drought resistance, and fruit quality and yield. This has lead to gradually increasing sales over the past few years.

There seemed to be a hiccup I'm growth a year or two ago, farmers weren't returning to buy the product in the following year, this was concerning. As it turned out, many farmers weren't returning because their soil tests showed they still had adequate levels of K, because their product isn't a salt that dissolves and runs off so quickly in the rain, providing a real residual value to farmers who chose their product:
https://www.globenewswire.com/news-release/2022/01/24/2371462/0/en/Verde-launches-P4G-shareholder-earnings-strategy-after-securing-Banco-do-Brasil-financing-backed-by-future-sales-contracts.html

THE CEO Cristiano Veloso, has struggled to prevent dilution through the years, the Board worked for nothing more than shares for several years, he has developed a strong dislike of any further dilution and has recently worked some credit agreements on POs and loans for construction of their second plant. Cristiano calls this his paid for growth program and expects to be able to begin to implement some capital allocation programs from their ongoing profitability:
https://www.globenewswire.com/news-release/2022/01/24/2371462/0/en/Verde-launches-P4G-shareholder-earnings-strategy-after-securing-Banco-do-Brasil-financing-backed-by-future-sales-contracts.html

Then the US and allies sanctioned Belarus and Russian potash, Lithuania closed a critical rail line for Belarus to export their KCl. Potash prices have gone from under $300 a year ago to over $1,000 at present. While it's not clear Brazil is going to ban Bela-russian Potash, the market has set the price much higher already and it seems that Verde will be able to sell every ounce they can dig of their material at market prices.

This is a very comprehensive video overview of the company to get you acquainted with the company:

Recent awareness of how the chloride in KCl is destroying soil bacteria, which is reducing the carbon absorption capacity of the soil biome provides another interesting catalyst. Woody Harilson's documentary "Kiss the Ground" has brought this issue to light and Cristiano says watching the documentary is a prerequisite for owning his shares. Then just last week the company announced they are introducing a product that contains beneficial bacteria and filed for a patent to begin adding beneficial bacteria to their fertilizer, which helps make the nutrients more readily available, and could potentially work into a carbon credit for use of their product sometime in the future:
https://investor.verde.ag/verde-launches-bio-revolution/

Watch the videos and look for the farmer testimonials videos on Youtube, they really seem to have convinced a lot of farmers their potash is superior to conventional sources.

Ultimately, the company's old PFS showed they had $48 billion of reserves of their material in the ground @ $250/ton prices, they are coming out with a new PFS soon that will use a $368/ton price while current prices are actually over $1,000/ton:
https://investor.verde.ag/verde-releases-market-study-and-provides-update-on-new-pre-feasibility-study/

[Bobwins]

SYTA has never delivered on promised of 4G and beyond technology. For some reason first responders in US and overseas have never adopted their 4G cell unit in big numbers. When I first invested in Siyata, they had annual sales of $20 million/yr selling mostly their 3G unit overseas. Sales since they switched to the 4G product have never come close. They are doing better with their rugged hand held devices and signal boosting products than the 4G product. Been losing money for years and continuously raising money.

Glad I finally gave up a few years ago. Bobwins

[CPTMatt]

SYTA - checked in on this today and not doing well which sucks. Haven't been following story since I sold long ago.